FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

JAN COEN NETELENBOS

Research Profile

Chemicals & Drugs

Procedures

Physiology

Postmenopause

Anatomy

Bone and Bones

Concepts & Ideas

Disorders

Co-author Network

Publications

TOP 3
George Ioannidis; Andrea Z LaCroix; R Lindsay; JAN COEN NETELENBOS; Alexandra Papaioannou; J Pfeilschifter; Laura Pickard; M Rossini; C Roux; Kenneth G Saag; P N Sambrook; S Silverman; Ethel S Siris; Nelson B Watts; Jonathan D Adachi; F A Anderson; S Boonen; Roland D Chapurlat; Juliet E Compston; C Cooper; A Díez-Perez; J Flahive; S H Gehlbach; S L Greenspan; F H Hooven
Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW).
Elaine M Dennison; Adolfo Díez-Pérez; Julie Flahive; Stephen H Gehlbach; Susan L Greenspan; Frederick H Hooven; Andrea Z LaCroix; Robert Lindsay; JAN COEN NETELENBOS; Johannes Pfeilschifter; Melissa Premaor; Maurizio Rossini; Christian Roux; Kenneth G Saag; Philip Sambrook; Stuart Silverman; Ethel S Siris; Nelson B Watts; Jonathan D Adachi; Frederick A Anderson; Steven Boonen; Roland Chapurlat; Juliet E Compston; Cyrus Cooper
Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW).
Stephen Gehlbach; Susan L Greenspan; Fred H Hooven; Andrea Z LaCroix; Jonathan D Adachi; Steven Boonen; Roland D Chapurlat; Juliet E Compston; Cyrus Cooper; Adolfo Díez-Perez; Julie Flahive; JAN COEN NETELENBOS; Johannes Pfeilschifter; Maurizio Rossini; Christian Roux; Kenneth G Saag; Philip N Sambrook; Stuart Silverman; Ethel S Siris; Nelson B Watts; Robert Lindsay
Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of JAN COEN NETELENBOS (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: George Ioannidis; Andrea Z LaCroix; R Lindsay; JAN COEN NETELENBOS; Alexandra Papaioannou; J Pfeilschifter; Laura Pickard; M Rossini; C Roux; Kenneth G Saag; P N Sambrook; S Silverman; Ethel S Siris; Nelson B Watts; Jonathan D Adachi; F A Anderson; S Boonen; Roland D Chapurlat; Juliet E Compston; C Cooper; A Díez-Perez; J Flahive; S H Gehlbach; S L Greenspan; F H Hooven
Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW).
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2013;24(1):59-67.
2012: Elaine M Dennison; Adolfo Díez-Pérez; Julie Flahive; Stephen H Gehlbach; Susan L Greenspan; Frederick H Hooven; Andrea Z LaCroix; Robert Lindsay; JAN COEN NETELENBOS; Johannes Pfeilschifter; Melissa Premaor; Maurizio Rossini; Christian Roux; Kenneth G Saag; Philip Sambrook; Stuart Silverman; Ethel S Siris; Nelson B Watts; Jonathan D Adachi; Frederick A Anderson; Steven Boonen; Roland Chapurlat; Juliet E Compston; Cyrus Cooper
Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW).
Bone 2012;50(6):1288-93.
2012: Stephen Gehlbach; Susan L Greenspan; Fred H Hooven; Andrea Z LaCroix; Jonathan D Adachi; Steven Boonen; Roland D Chapurlat; Juliet E Compston; Cyrus Cooper; Adolfo Díez-Perez; Julie Flahive; JAN COEN NETELENBOS; Johannes Pfeilschifter; Maurizio Rossini; Christian Roux; Kenneth G Saag; Philip N Sambrook; Stuart Silverman; Ethel S Siris; Nelson B Watts; Robert Lindsay
Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2012;27(3):645-53.
2011: Juliet E Compston; Cyrus Cooper; Adolfo Díez-Pérez; Julie Flahive; Stephen Gehlbach; Susan Greenspan; Frederick H Hooven; Andrea Z LaCroix; Robert Lindsay; JAN COEN NETELENBOS; Johannes Pfeilschifter; Maurizio Rossini; Christian Roux; Kenneth G Saag; Philip N Sambrook; Stuart Silverman; Ethel S Siris; Nelson B Watts; Jonathan D Adachi; Steven Boonen; Roland Chapurlat
Obesity is not protective against fracture in postmenopausal women: GLOW.
The American journal of medicine 2011;124(11):1043-50.
2011: Philip N Sambrook; Stuart Silverman; Ethel S Siris; Nelson B Watts; Jonathan D Adachi; Steven Boonen; Roland Chapurlat; Juliet E Compston; Cyrus Cooper; Adolfo Díez-Perez; Julie Flahive; Susan L Greenspan; Fred H Hooven; David Hosmer; Andrea LaCroix; Robert Lindsay; JAN COEN NETELENBOS; Tuan V Nguyen; Johannes Pfeilschifter; Maurizio Rossini; Christian Roux; Kenneth G Saag; Stephen Gehlbach
Predicting fractures in an international cohort using risk factor algorithms without BMD.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2011;26(11):2770-7.
2011: Adolfo Díez-Pérez; Jonathan D Adachi; Silvano Adami; Frederick A Anderson; Steven Boonen; Roland D Chapurlat; Juliet E Compston; Cyrus Cooper; Pierre Delmas; Susan L Greenspan; Frederick H Hooven; Andrea Z LaCroix; Robert Lindsay; JAN COEN NETELENBOS; Grigor Nika; Johannes Pfeilschifter; Christian Roux; Kenneth G Saag; Philip Sambrook; Stuart Silverman; Ethel S Siris; Nelson B Watts; Stephen H Gehlbach
Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW).
Bone 2011;49(3):493-8.
2011: JAN COEN NETELENBOS; Piet Geusens; G Ypma; S J E Buijs
Adherence and profile of non-persistence in patients treated for osteoporosis--a large-scale, long-term retrospective study in The Netherlands.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2011;22(5):1537-46.
2011: Anton A M Franken; Nico J C van Blijderveen; Max J H Witjes; JAN COEN NETELENBOS
[Bisphosphonate-related osteonecrosis of the jaw].
Nederlands tijdschrift voor geneeskunde 2011;155():A3077.
2011: Angela E Oostlander; Nathalie Bravenboer; Evelien Sohl; Paulien J Holzmann; Christien J van der Woude; Gerard Dijkstra; Pieter C F Stokkers; Bas Oldenburg; JAN COEN NETELENBOS; Daniel W Hommes; Ad van Bodegraven; Paul Lips
Histomorphometric analysis reveals reduced bone mass and bone formation in patients with quiescent Crohn's disease.
Gastroenterology 2011;140(1):116-23.
2010: Jonathan D Adachi; Silvano Adami; Stephen Gehlbach; Frederick A Anderson; Steven Boonen; Roland D Chapurlat; Juliet E Compston; Cyrus Cooper; Pierre Delmas; Adolfo Díez-Pérez; Susan L Greenspan; Frederick H Hooven; Andrea Z LaCroix; Robert Lindsay; JAN COEN NETELENBOS; Olivia Wu; Johannes Pfeilschifter; Christian Roux; Kenneth G Saag; Philip N Sambrook; Stuart Silverman; Ethel S Siris; Grigor Nika; Nelson B Watts
Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women.
Mayo Clinic proceedings. Mayo Clinic 2010;85(9):806-13.
2009: JAN COEN NETELENBOS; Willem F Lems; P P Geusens; H J Verhaar; A J M Boermans; M M Boomsma; P G H Mulder; S E Papapoulos
Spine radiographs to improve the identification of women at high risk for fractures.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2009;20(8):1347-52.
2009: Annemieke C Heijboer; JAN COEN NETELENBOS; Marinus A Blankenstein
Meningioma in untreated congenital adrenal hyperplasia: a relationship?
Journal of neuro-oncology 2009;92(2):223-5.
2008: Helge Raeder; Nick Shaw; JAN COEN NETELENBOS; Robert Bjerknes
A case of X-linked hypophosphatemic rickets: complications and the therapeutic use of cinacalcet.
European journal of endocrinology / European Federation of Endocrine Societies 2008;159 Suppl 1():S101-5.
2007: Suat Simsek; Natalja M Basoski; Nathalie Bravenboer; Xiafang Zhang; Steven Mumm; Michael P Whyte; JAN COEN NETELENBOS
Sporadic hyperphosphatasia syndrome featuring periostitis and accelerated skeletal turnover without receptor activator of nuclear factor-kappaB, osteoprotegerin, or sequestosome-1 gene defects.
The Journal of clinical endocrinology and metabolism 2007;92(5):1897-901.
2006: Suat Simsek; Paul Lips; Emiel Comans; JAN COEN NETELENBOS
Paradoxical reaction on treatment with 131I.
Thyroid : official journal of the American Thyroid Association 2006;16(12):1321-2.
2006: G Sophie Mijnhout; H Kloosterman; Suat Simsek; R J M Strack van Schijndel; JAN COEN NETELENBOS
Oxybutynin: dry days for patients with hyperhidrosis.
The Netherlands journal of medicine 2006;64(9):326-8.
2006: Rutger Goekoop; Frederik Barkhof; Erik J J Duschek; JAN COEN NETELENBOS; Dirk L Knol; Philip scheltens; Serge A R B Rombouts
Raloxifene treatment enhances brain activation during recognition of familiar items: a pharmacological fMRI study in healthy elderly males.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(7):1508-18.
2006: Willem F Lems; Neveen Agnes Therese Hamdy; JAN COEN NETELENBOS
[Teriparatide: an anabolic drug for the treatment of patients with osteoporosis].
Nederlands tijdschrift voor geneeskunde 2006;150(3):132-7.
2005: S Simsek; K Janssens; Mei Lan Kwee; Wim Van Hul; J Veenstra; JAN COEN NETELENBOS
Camurati-Engelmann disease (progressive diaphyseal dysplasia) in a Moroccan family.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2005;16(9):1167-70.
2005: Erik J J Duschek; Louis J G Gooren; JAN COEN NETELENBOS
Comparison of effects of the rise in serum testosterone by raloxifene and oral testosterone on serum insulin-like growth factor-1 and insulin-like growth factor binding protein-3.
Maturitas 2005;51(3):286-93.
2005: Tatjana E Vogelvang; Velja Mijatovic; Marius J van der Mooren; Ursula Pinsdorf; Klaus Von Bergmann; JAN COEN NETELENBOS; Dieter Lütjohann
Effect of raloxifene and hormone therapy on serum markers of brain and whole-body cholesterol metabolism in postmenopausal women.
Maturitas 2005;50(4):312-20.
2005: JAN COEN NETELENBOS; Petra J G Zwijnenburg; Piet M ter Wee
Risk factors determining active urinary stone formation in patients with urolithiasis.
Clinical nephrology 2005;63(3):188-92.
2005: Rutger Goekoop; Erik J J Duschek; Dirk L Knol; Frederik Barkhof; JAN COEN NETELENBOS; Philip scheltens; Serge A R B Rombouts
Raloxifene exposure enhances brain activation during memory performance in healthy elderly males; its possible relevance to behavior.
NeuroImage 2005;25(1):63-75.
2004: Erik J J Duschek; Simone J M Neele; M Christella L G D Thomassen; Jan Rosing; JAN COEN NETELENBOS
Effect of raloxifene on activated protein C (APC) resistance in postmenopausal women and on APC resistance and homocysteine levels in elderly men: two randomized placebo-controlled studies.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(8):649-55.
2004: Erik J Giltay; Erik J J Duschek; Martijn B Katan; Peter L Zock; Simone J M Neele; JAN COEN NETELENBOS
Raloxifene and hormone replacement therapy increase arachidonic acid and docosahexaenoic acid levels in postmenopausal women.
The Journal of endocrinology 2004;182(3):399-408.
2004: Erik J J Duschek; Gerdien W de Valk-de Roo; Louis J G Gooren; JAN COEN NETELENBOS
Effects of conjugated equine estrogen vs. raloxifene on serum insulin-like growth factor-i and insulin-like growth factor binding protein-3: a 2-year, double-blind, placebo-controlled study.
Fertility and sterility 2004;82(2):384-90.
2004: Ian R Reid; Ana Munoz; Ignac Fogelman; Jonathon D Adachi; Amy Rosen; JAN COEN NETELENBOS; Nelson B Watts; Ego Seeman; Angelina V Ciaccia; Michael W Draper
A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.
Archives of internal medicine 2004;164(8):871-9.
2004: Willem F Lems; JAN COEN NETELENBOS
[The Dutch Institute for Health Care Improvement (CBO) guideline for the diagnosis and treatment of aspecific acute and chronic low back complaints].
Nederlands tijdschrift voor geneeskunde 2004;148(17):858-9; author reply 859.
2004: Erik J J Duschek; Louis J G Gooren; JAN COEN NETELENBOS
Effects of raloxifene on gonadotrophins, sex hormones, bone turnover and lipids in healthy elderly men.
European journal of endocrinology / European Federation of Endocrine Societies 2004;150(4):539-46.
2004: Mariette C Lodder; Willem F Lems; Herman J Ader; A E Marthinsen; S C C M van Coeverden; Paul Lips; JAN COEN NETELENBOS; B A C Dijkmans; Jan C Roos
Reproducibility of bone mineral density measurement in daily practice.
Annals of the rheumatic diseases 2004;63(3):285-9.
2004: M W G Vandenbroucke; Rutger Goekoop; Erik J J Duschek; JAN COEN NETELENBOS; Joost P A Kuijer; Frederik Barkhof; Philip scheltens; Serge A R B Rombouts
Interindividual differences of medial temporal lobe activation during encoding in an elderly population studied by fMRI.
NeuroImage 2004;21(1):173-80.
2004: Tatjana E Vogelvang; Judith Leurs; Marius J van der Mooren; Velja Mijatovic; Dirk F Hendriks; Simone J M Neele; JAN COEN NETELENBOS; Peter Kenemans
Raloxifene reduces procarboxypeptidase U, an antifibrinolytic marker. A 2-year randomized, placebo-controlled study in healthy early postmenopausal women.
Menopause (New York, N.Y.) 2004;11(1):110-5.
2003: Erik J J Duschek; C D A Stehouwer; Gerdien W de Valk-de Roo; Casper G Schalkwijk; J Lambert; JAN COEN NETELENBOS
Raloxifene, conjugated oestrogen and endothelial function in postmenopausal women.
Journal of internal medicine 2003;254(1):85-94.
2003: Tom Teerlink; Simone J M Neele; S de Jong; JAN COEN NETELENBOS; C D A Stehouwer
Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women.
Clinical science (London, England : 1979) 2003;105(1):67-71.
2002: JAN COEN NETELENBOS
An update on non-gynaecological effects of SERM's and aromatase inhibitors.
European journal of cancer (Oxford, England : 1990) 2002;38 Suppl 6():S63-4.
2002: S C C M van Coeverden; JAN COEN NETELENBOS; CM de Ridder; Jan C Roos; Corry Popp-Snijders; Henriette A Delemarre-Van De Waal
Bone metabolism markers and bone mass in healthy pubertal boys and girls.
Clinical endocrinology 2002;57(1):107-16.
2002: Simone J M Neele; Reinder Evertz; Andrea R Genazzani; Michele Luisi; JAN COEN NETELENBOS
Raloxifene treatment increases plasma levels of beta-endorphin in postmenopausal women: a randomized, placebo-controlled study.
Fertility and sterility 2002;77(6):1110-7.
2002: Caroline Brumsen; Socrates E Papapoulos; Paul Lips; Petronella H L M Geelhoed-Duijvestijn; Neveen Agnes Therese Hamdy; Jan Otto Landman; Eugene V McCloskey; JAN COEN NETELENBOS; Ernest K J Pauwels; Jan C Roos; Rob M Valentijn; Aeilko H Zwinderman
Daily oral pamidronate in women and men with osteoporosis: a 3-year randomized placebo-controlled clinical trial with a 2-year open extension.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2002;17(6):1057-64.
2002: Bruno Pornel; Olivier Chevallier; JAN COEN NETELENBOS
Oral 17beta-estradiol (1 mg) continuously combined with dydrogesterone improves the serum lipid profile of postmenopausal women.
Menopause (New York, N.Y.) 2002;9(3):171-8.
2002: Tatjana E Vogelvang; Velja Mijatovic; Otto Kamp; JAN COEN NETELENBOS; Simone J M Neele; Amos Pines; Peter Kenemans; Marius J van der Mooren
Neither long-term treatment with raloxifene nor hormone replacement therapy modulate cardiac function in healthy postmenopausal women: two randomized, placebo-controlled, 2-year studies.
American journal of obstetrics and gynecology 2002;186(4):729-36.
2002: Simone J M Neele; Reinder Evertz; Gerdien W de Valk-de Roo; Jan C Roos; JAN COEN NETELENBOS
Effect of 1 year of discontinuation of raloxifene or estrogen therapy on bone mineral density after 5 years of treatment in healthy postmenopausal women.
Bone 2002;30(4):599-603.
2002: Raimond G V Smolders; Tatjana E Vogelvang; Velja Mijatovic; W Marchien van Baal; Simone J M Neele; JAN COEN NETELENBOS; Peter Kenemans; Marius J van der Mooren
A 2-year, randomized, comparative, placebo-controlled study on the effects of raloxifene on lipoprotein(a) and homocysteine.
Maturitas 2002;41(2):105-14.
2001: S C C M van Coeverden; JAN COEN NETELENBOS; Jan C Roos; CM de Ridder; Henriette A Delemarre-Van De Waal
[Reference values for bone mass in Dutch white pubertal children and their relation to pubertal maturation characteristics].
Nederlands tijdschrift voor geneeskunde 2001;145(38):1851-6.
2001: Marinka S Post; Marius J van der Mooren; W Marchien van Baal; Simone J M Neele; JAN COEN NETELENBOS; Peter Kenemans
Raloxifene reduces impedance to flow within the uterine artery in early postmenopausal women: a 2-year randomized, placebo-controlled, comparative study.
American journal of obstetrics and gynecology 2001;185(3):557-62.
2001: S C C M van Coeverden; CM de Ridder; Jan C Roos; M A Van't Hof; JAN COEN NETELENBOS; Henriette A Delemarre-Van De Waal
Pubertal maturation characteristics and the rate of bone mass development longitudinally toward menarche.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2001;16(4):774-81.
2001: Simone J M Neele; Serge A R B Rombouts; M A Bierlaagh; Frederik Barkhof; Philip scheltens; JAN COEN NETELENBOS
Raloxifene affects brain activation patterns in postmenopausal women during visual encoding.
The Journal of clinical endocrinology and metabolism 2001;86(3):1422-4.
2000: Gerdien W de Valk-de Roo; Coen D A Stehouwer; Jef J Emeis; A Nicolaas-Merkus; JAN COEN NETELENBOS
Unopposed estrogen increases total plasma factor VII, but not active factor VII--a short-term placebo-controlled study in healthy postmenopausal women.
Thrombosis and haemostasis 2000;84(6):968-72.
2000: M Dijkgraaf-Ten Bolscher; Simone J M Neele; Rob Barto; Wim J F van der Vijgh; JAN COEN NETELENBOS
Effect of estrogen on intestinal strontium absorption in postmenopausal women.
Maturitas 2000;36(3):195-201.
2000: Simone J M Neele; W Marchien van Baal; Marius J van der Mooren; H Kessel; JAN COEN NETELENBOS; Peter Kenemans
Ultrasound assessment of the endometrium in healthy, asymptomatic early post-menopausal women: saline infusion sonohysterography versus transvaginal ultrasound.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2000;16(3):254-9.
2000: M Dijkgraaf-Ten Bolscher; Rob Barto; Daphne Voorn; D Compas; JAN COEN NETELENBOS; Wim J F van der Vijgh
Influence of ovariectomy on extracellular fluid volume in rats: assessment of extracellular fluid volume by means of bromide.
The Journal of laboratory and clinical medicine 2000;135(4):303-8.
2000: M Dijkgraaf-Ten Bolscher; JAN COEN NETELENBOS; Rob Barto; Wim J F van der Vijgh
Strontium as a marker for intestinal calcium absorption: the stimulatory effect of calcitriol.
Clinical chemistry 2000;46(2):248-51.
1999: Gerdien W de Valk-de Roo; Coen D A Stehouwer; Piet Meijer; Velja Mijatovic; Cornelis Kluft; Peter Kenemans; Fredric Cohen; S Watts; JAN COEN NETELENBOS
Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(12):2993-3000.
1999: Jolanda M H Elbers; G W de Roo; Corry Popp-Snijders; A Nicolaas-Merkus; E Westerveen; B W Joenje; JAN COEN NETELENBOS
Effects of administration of 17beta-oestradiol on serum leptin levels in healthy postmenopausal women.
Clinical endocrinology 1999;51(4):449-54.
1999: Gerdien W de Valk-de Roo; Coen D A Stehouwer; J Lambert; Casper G Schalkwijk; Marius J van der Mooren; Cornelis Kluft; JAN COEN NETELENBOS
Plasma homocysteine is weakly correlated with plasma endothelin and von Willebrand factor but not with endothelium-dependent vasodilatation in healthy postmenopausal women.
Clinical chemistry 1999;45(8 Pt 1):1200-5.
1999: M ten Bolscher; JAN COEN NETELENBOS; Rob Barto; L M Van Buuren; Wim J F van der Vijgh
Estrogen regulation of intestinal calcium absorption in the intact and ovariectomized adult rat.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1999;14(7):1197-202.
1999: Velja Mijatovic; Marius J van der Mooren; Coen D A Stehouwer; JAN COEN NETELENBOS; Peter Kenemans
Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1999;13(2):130-44.
1999: M ten Bolscher; Gerdien W de Valk-de Roo; Rob Barto; Wim J F van der Vijgh; JAN COEN NETELENBOS
Oestrogen has no short-term effect on intestinal strontium absorption in healthy postmenopausal women.
Clinical endocrinology 1999;50(3):387-92.
1999: J J Hoorweg-Nijman; G Kardos; Jan C Roos; H J van Dijk; JAN COEN NETELENBOS; Corry Popp-Snijders; CM de Ridder; Henriette A Delemarre-Van De Waal
Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia.
Clinical endocrinology 1999;50(2):237-44.
1999: Nathalie Bravenboer; S E Papapoulos; Paulien J Holzmann; Neveen Agnes Therese Hamdy; JAN COEN NETELENBOS; Paul Lips
Bone histomorphometric evaluation of pamidronate treatment in clinically manifest osteoporosis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1999;9(6):489-93.
1999: Velja Mijatovic; Marius J van der Mooren; Peter Kenemans; Gerdien W de Valk-de Roo; JAN COEN NETELENBOS
Raloxifene lowers serum lipoprotein(A) in healthy postmenopausal women: a randomized, double-blind, placebo-controlled comparison with conjugated equine estrogens.
Menopause (New York, N.Y.) 1999;6(2):134-7.
1998: Velja Mijatovic; JAN COEN NETELENBOS; Marius J van der Mooren; Gerdien W de Valk-de Roo; Cornelis Jakobs; Peter Kenemans
Randomized, double-blind, placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women.
Fertility and sterility 1998;70(6):1085-9.
1998: JAN COEN NETELENBOS
Osteoporosis: intervention options.
Maturitas 1998;30(3):235-9.
1998: Willem F Lems; J W Jacobs; JAN COEN NETELENBOS; B A Dijkmans; J W Bijlsma
[Pharmacological prevention of osteoporosis in patients on corticosteroid medication].
Nederlands tijdschrift voor geneeskunde 1998;142(34):1904-8.
1998: M F Schreuder; A P van Driel; Arthur van Lingen; J C Roos; CM de Ridder; Radu A Manoliu; Erik F L David; JAN COEN NETELENBOS
Volumetric measurements of bone mineral density of the lumbar spine: comparison of three geometrical approximations using dual-energy X-ray absorptiometry (DXA)
Nuclear medicine communications 1998;19(8):727-33.
1998: Velja Mijatovic; Peter Kenemans; JAN COEN NETELENBOS; Cornelis Jakobs; Corry Popp-Snijders; ER Peters-Muller; Marius J van der Mooren
Postmenopausal oral 17beta-estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels.
Fertility and sterility 1998;69(5):876-82.
1997: Gerdien W de Valk-de Roo; JAN COEN NETELENBOS; I R Peters-Muller; GA Voetberg; Peter H M van de Weijer; Anneke A Bouman; Corry Popp-Snijders; Peter Kenemans
Continuously combined hormone replacement therapy and bone turnover: the influence of dydrogesterone dose, smoking and initial degree of bone turnover.
Maturitas 1997;28(2):153-62.
1997: Velja Mijatovic; Peter Kenemans; JAN COEN NETELENBOS; ER Peters-Muller; Gerard J van Kamp; GA Voetberg; Peter H M van de Weijer; Marius J van der Mooren
Oral 17 beta-estradiol continuously combined with dydrogesterone lowers serum lipoprotein(a) concentrations in healthy postmenopausal women.
The Journal of clinical endocrinology and metabolism 1997;82(11):3543-7.
1997: M C Slootweg; D Swolin; JAN COEN NETELENBOS; Olle G P Isaksson; C Ohlsson
Estrogen enhances growth hormone receptor expression and growth hormone action in rat osteosarcoma cells and human osteoblast-like cells.
The Journal of endocrinology 1997;155(1):159-64.
1997: A J Sips; Rob Barto; JAN COEN NETELENBOS; Wim J F van der Vijgh
Preclinical screening of the applicability of strontium as a marker for intestinal calcium absorption.
The American journal of physiology 1997;272(3 Pt 1):E422-8.
1996: Anneke A Bouman; CM de Ridder; J H Nijhof; JAN COEN NETELENBOS; H A Delemarre-vd Waal
Immunoadsorption assay for bone alkaline phosphatase compared with wheat germ agglutinin precipitation assay in serum from (pre)pubertal girls.
Clinical chemistry 1996;42(12):1970-4.
1996: F J Broekmans; Peter G A Hompes; M A Heitbrink; JAN COEN NETELENBOS; J C Roos; T M Falke; Joop Schoemaker
Two-step gonadotropin-releasing hormone agonist treatment of uterine leiomyomas: standard-dose therapy followed by reduced-dose therapy.
American journal of obstetrics and gynecology 1996;175(5):1208-16.
1996: Corry Popp-Snijders; Paul Lips; JAN COEN NETELENBOS
Intra-individual variation in bone resorption markers in urine.
Annals of clinical biochemistry 1996;33 ( Pt 4)():347-8.
1996: A J Sips; Wim J F van der Vijgh; Rob Barto; JAN COEN NETELENBOS
Intestinal absorption of strontium chloride in healthy volunteers: pharmacokinetics and reproducibility.
British journal of clinical pharmacology 1996;41(6):543-9.
1995: A J Sips; Wim J F van der Vijgh; Rob Barto; JAN COEN NETELENBOS
Intestinal strontium absorption: from bioavailability to validation of a simple test representative for intestinal calcium absorption.
Clinical chemistry 1995;41(10):1446-50.
1995: Rob Barto; A J Sips; Wim J F van der Vijgh; JAN COEN NETELENBOS
Sensitive method for analysis of strontium in human and animal plasma by graphite furnace atomic absorption spectrophotometry.
Clinical chemistry 1995;41(8 Pt 1):1159-63.
1995: A J Sips; JAN COEN NETELENBOS; Rob Barto; Wim J F van der Vijgh
Measurement of intestinal calcium absorption by using stable strontium.
Clinical science (London, England : 1979) 1995;89(1):107.
1995: Anneke A Bouman; P G Scheffer; M E Ooms; P Lips; JAN COEN NETELENBOS
Two bone alkaline phosphatase assays compared with osteocalcin as a marker of bone formation in healthy elderly women.
Clinical chemistry 1995;41(2):196-9.
1994: G A Voetberg; JAN COEN NETELENBOS; Peter Kenemans; ER Peters-Muller; Peter H M van de Weijer
Estrogen replacement therapy continuously combined with four different dosages of dydrogesterone: effect on calcium and lipid metabolism.
The Journal of clinical endocrinology and metabolism 1994;79(5):1465-9.
1994: P J Elders; Paul Lips; JAN COEN NETELENBOS; FC Van Ginkel; E Khoe; Wim J F van der Vijgh; Paul van der Stelt
Long-term effect of calcium supplementation on bone loss in perimenopausal women.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1994;9(7):963-70.
1994: A J Sips; JAN COEN NETELENBOS; Rob Barto; C A Verburgh; C Nieboer; Wim J F van der Vijgh
Topically applied low-dose calcitriol has no calciotropic effect in patients with stable plaque psoriasis.
Journal of the American Academy of Dermatology 1994;30(6):966-9.
1994: A Oldenhave; JAN COEN NETELENBOS
Pathogenesis of climacteric complaints: ready for the change?
Lancet 1994;343(8898):649-53.
1994: A J Sips; JAN COEN NETELENBOS; Rob Barto; Paul Lips; Wim J F van der Vijgh
One-hour test for estimating intestinal absorption of calcium by using stable strontium as a marker.
Clinical chemistry 1994;40(2):257-9.
1993: H E van der Wiel; Paul Lips; J Nauta; G Kwakkel; G Hazenberg; JAN COEN NETELENBOS; Wim J F van der Vijgh
Intranasal calcitonin suppresses increased bone resorption during short-term immobilization: a double-blind study of the effects of intranasal calcitonin on biochemical parameters of bone turnover.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1993;8(12):1459-65.
1993: L van Doorn; Paul Lips; JAN COEN NETELENBOS; W H Hackeng
Bone histomorphometry and serum concentrations of intact parathyroid hormone (PTH(1-84)) in patients with primary hyperparathyroidism.
Bone and mineral 1993;23(3):233-42.
1993: O R Leeuwenkamp; H E van der Wiel; Paul Lips; Wim J F van der Vijgh; Rob Barto; H Greuter; JAN COEN NETELENBOS
Human pharmacokinetics of orally administered (24 R)-hydroxycalcidiol.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1993;31(7):419-26.
1993: H E van der Wiel; Paul Lips; P C Huijgens; JAN COEN NETELENBOS
Effects of short-term low-dose heparin administration on biochemical parameters of bone turnover.
Bone and mineral 1993;22(1):27-32.
1992: P J Elders; L L Habets; JAN COEN NETELENBOS; L W van der Linden; Paul van der Stelt
The relation between periodontitis and systemic bone mass in women between 46 and 55 years of age.
Journal of clinical periodontology 1992;19(7):492-6.
1991: P J Elders; JAN COEN NETELENBOS; Paul Lips; FC Van Ginkel; E Khoe; O R Leeuwenkamp; W H Hackeng; Paul van der Stelt
Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age.
The Journal of clinical endocrinology and metabolism 1991;73(3):533-40.
1991: Paul Lips; JAN COEN NETELENBOS; L van Doorn; W H Hackeng; C J Lips
Stimulation and suppression of intact parathyroid hormone (PTH1-84) in normal subjects and hyperparathyroid patients.
Clinical endocrinology 1991;35(1):35-40.
1991: JAN COEN NETELENBOS; M T Siregar-Emck; L P Schot; FC Van Ginkel; Paul Lips; O R Leeuwenkamp
Short-term effects of Org OD 14 and 17 beta-oestradiol on bone and lipid metabolism in early post-menopausal women.
Maturitas 1991;13(2):137-49.
1991: H E van der Wiel; Paul Lips; J Nauta; JAN COEN NETELENBOS; G J Hazenberg
Biochemical parameters of bone turnover during ten days of bed rest and subsequent mobilization.
Bone and mineral 1991;13(2):123-9.
1991: JAN COEN NETELENBOS; FC Van Ginkel; Paul Lips; O R Leeuwenkamp; Rob Barto; Wim J F van der Vijgh; H van der Wiel; W H Hackeng
Effect of a single infusion of aminohydroxypropylidene on calcium and bone metabolism in healthy volunteers monitored during 2 months.
The Journal of clinical endocrinology and metabolism 1991;72(1):223-8.
1990: O R Leeuwenkamp; Wim J F van der Vijgh; B C Hüsken; Paul Lips; JAN COEN NETELENBOS
Human pharmacokinetics of orally administered strontium.
Calcified tissue international 1990;47(3):136-41.
1990: Paul Lips; FC Van Ginkel; JAN COEN NETELENBOS; A Wiersinga; Wim J F van der Vijgh
Lower mobility and markers of bone resorption in the elderly.
Bone and mineral 1990;9(1):49-57.
1990: W G M Geraets; Paul van der Stelt; JAN COEN NETELENBOS; P J Elders
A new method for automatic recognition of the radiographic trabecular pattern.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1990;5(3):227-33.
1989: P J Elders; JAN COEN NETELENBOS; Paul Lips; E Khoe; FC Van Ginkel; K F Hulshof; Paul van der Stelt
Perimenopausal bone mass and risk factors.
Bone and mineral 1989;7(3):289-99.
1989: M Jongen; Wim J F van der Vijgh; JAN COEN NETELENBOS; G J Postma; Paul Lips
Pharmacokinetics of 24,25-dihydroxyvitamin D3 in humans.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1989;21(10):577-80.
1989: Paul Lips; Henk Asscheman; P Uitewaal; JAN COEN NETELENBOS; Louis J G Gooren
The effect of cross-gender hormonal treatment on bone metabolism in male-to-female transsexuals.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1989;4(5):657-62.
1989: O R Leeuwenkamp; Wim J F van der Vijgh; B C Hüsken; Paul Lips; JAN COEN NETELENBOS
Quantification of strontium in plasma and urine with flameless atomic absorption spectrometry.
Clinical chemistry 1989;35(9):1911-4.
1989: Tom Teerlink; P Tavenier; JAN COEN NETELENBOS
Selective determination of hydroxyproline in urine by high-performance liquid chromatography using precolumn derivatization.
Clinica chimica acta; international journal of clinical chemistry 1989;183(3):309-15.
1988: Paul Lips; A Wiersinga; FC Van Ginkel; M J Jongen; JAN COEN NETELENBOS; W H Hackeng; P D Delmas; Wim J F van der Vijgh
The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects.
The Journal of clinical endocrinology and metabolism 1988;67(4):644-50.
1988: P J Elders; JAN COEN NETELENBOS; Paul Lips; FC Van Ginkel; Paul van der Stelt
Accelerated vertebral bone loss in relation to the menopause: a cross-sectional study on lumbar bone density in 286 women of 46 to 55 years of age.
Bone and mineral 1988;5(1):11-9.
1988: M J Jongen; S Kuiper; Wim J F van der Vijgh; Paul Lips; JAN COEN NETELENBOS
Improvements in the simultaneous determination of calcidiol and calcitriol in human serum or plasma.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1988;26(1):25-8.
1987: Paul Lips; FC Van Ginkel; M J Jongen; F Rubertus; Wim J F van der Vijgh; JAN COEN NETELENBOS
Determinants of vitamin D status in patients with hip fracture and in elderly control subjects.
The American journal of clinical nutrition 1987;46(6):1005-10.
1987: P J Uitewaal; Paul Lips; JAN COEN NETELENBOS
An analysis of bone structure in patients with hip fracture.
Bone and mineral 1987;3(1):63-73.
1986: JAN COEN NETELENBOS; Henk Asscheman; Paul Lips; Wim J F van der Vijgh; M J Jongen; FC Van Ginkel; W H Hackeng
Absence of effect of 24,25-dihydroxyvitamin D3 in primary hyperparathyroidism.
The Journal of clinical endocrinology and metabolism 1986;63(1):246-8.
1985: JAN COEN NETELENBOS; M J Jongen; Wim J F van der Vijgh; Paul Lips; FC Van Ginkel
Vitamin D status in urinary calcium stone formation.
Archives of internal medicine 1985;145(4):681-4.
1985: Paul Lips; R Bouillon; M J Jongen; FC Van Ginkel; Wim J F van der Vijgh; JAN COEN NETELENBOS
The effect of trauma on serum concentrations of vitamin D metabolites in patients with hip fracture.
Bone 1985;6(2):63-7.
1984: M J Jongen; FC Van Ginkel; Wim J F van der Vijgh; S Kuiper; JAN COEN NETELENBOS; Paul Lips
An international comparison of vitamin D metabolite measurements.
Clinical chemistry 1984;30(3):399-403.
1984: M J Jongen; Wim J F van der Vijgh; Paul Lips; JAN COEN NETELENBOS
Measurement of vitamin D metabolites in anephric subjects.
Nephron 1984;36(4):230-4.
1983: JAN COEN NETELENBOS; P Lips; C van der Meer
Hyperparathyroidism following irradiation of benign diseases of the head and neck.
Cancer 1983;52(3):458-61.
1983: Paul Lips; W H Hackeng; M J Jongen; FC Van Ginkel; JAN COEN NETELENBOS
Seasonal variation in serum concentrations of parathyroid hormone in elderly people.
The Journal of clinical endocrinology and metabolism 1983;57(1):204-6.
1982: M J Jongen; Wim J F van der Vijgh; E C van Beresteyn; H van den Berg; R Bosch; T Hoogenboezem; T J Visser; JAN COEN NETELENBOS
Interlaboratory variation of vitamin D1) metabolite measurements.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1982;20(10):753-6.
1982: Paul Lips; JAN COEN NETELENBOS; M J Jongen; FC Van Ginkel; A L Althuis; C L van Schaik; Wim J F van der Vijgh; J P Vermeiden; C van der Meer
Histomorphometric profile and vitamin D status in patients with femoral neck fracture.
Metabolic bone disease & related research 1982;4(2):85-93.
1981: M J Jongen; Wim J F van der Vijgh; H J Willems; JAN COEN NETELENBOS; Paul Lips
Simultaneous determination of 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D, and 1,25-dihydroxyvitamin D in plasma or serum.
Clinical chemistry 1981;27(10):1757-60.
1981: M J Jongen; Wim J F van der Vijgh; H J Willems; JAN COEN NETELENBOS
Analysis for 1,25-dihydroxyvitamin D in human plasma, after a liquid-chromatographic purification procedure, with a modified competitive protein-binding assay.
Clinical chemistry 1981;27(3):444-50.